IDEAYA Biosciences posts Q3 profit on Servier deal revenue
PositiveFinancial Markets

IDEAYA Biosciences has reported a profit for the third quarter, largely attributed to revenue generated from its partnership with Servier. This financial success highlights the effectiveness of their collaboration and positions IDEAYA for future growth. The deal not only boosts their financial standing but also reinforces their commitment to advancing innovative therapies, making it a significant milestone in their journey.
— Curated by the World Pulse Now AI Editorial System









